Welcome to our dedicated page for SLBT news (Ticker: SLBT), a resource for investors and traders seeking the latest updates and insights on SLBT stock.
The SLBT news page on Stock Titan focuses on developments related to SL Science Holding Limited and its connection to SL BIO Ltd. and Horizon Space Acquisition II Corp. SLBT is expected to be the ticker symbol for SL Science Holding Limited, the post-business combination holding company for SL BIO Ltd., a biomedical company that concentrates on cellular and gene therapies for regenerative medicine and cancer treatment.
News for SLBT will center on the progress of the proposed business combination between SL BIO Ltd. and Horizon Space Acquisition II Corp., a special purpose acquisition company (SPAC). Coverage includes milestones such as the effectiveness of the registration statement on Form F-4 with the U.S. Securities and Exchange Commission, scheduling and outcomes of shareholder meetings, and satisfaction of listing and closing conditions for the Nasdaq listing under the SLBT symbol.
Because SL BIO Ltd. operates in the biopharmaceutical space, SLBT-related news may also feature updates on its cellular and gene therapy programs, including work with immune stem cells, Armed-T and Gamma Delta T cell technologies, and bovine-derived milk exosome applications in tissue regeneration, skincare, and cancer recovery, when such information is disclosed in official communications.
Investors and observers can use this page to follow regulatory announcements, transaction-related disclosures, and corporate communications tied to the SPAC combination and the anticipated Nasdaq listing. Bookmark this feed to review new press releases and other news items as they are published through recognized newswire and disclosure channels.
SL BIO Ltd. (expected Nasdaq: SLBT) and Horizon Space Acquisition II Corp. announced the Form F-4 registration statement in connection with their proposed business combination was declared effective by the SEC on January 13, 2026. The definitive proxy/prospectus dated January 13, 2026 began mailing to shareholders on or about that date. HSPT will hold an extraordinary general meeting at 9:00 a.m. ET on February 3, 2026 to vote on the Proposed Transactions.
Upon closing and related transactions, the post-combination holding company, SL Science Holding Limited (PubCo), is expected to list on Nasdaq under the ticker SLBT. Closing remains subject to Nasdaq listing approval, HSPT shareholder approval, and satisfaction or waiver of customary closing conditions.
